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Abstract—In the context of cancer, internal "checkerboard" structures are normally found in the matrices of gene expression
data, which correspond to genes that are significantly up- or down-regulated in patients with specific types of tumors. In this
paper, we propose a novel method, called dual graph-regularization principal component analysis (DGPCA). The main
innovation of this method is that it simultaneously considers the internal geometric structures of the condition manifold and the
gene manifold. Specifically, we obtain principal components (PCs) to represent the data and approximate the cluster
membership indicators through Laplacian embedding. This new method is endowed with internal geometric structures, such as
the condition manifold and gene manifold, which are both suitable for bi-clustering. A closed-form solution is provided for
DGPCA. We apply this new method to simultaneously cluster genes and conditions (e.g., different samples) with the aim of
finding internal "checkerboard" structures on gene expression data, if they exist. Then, we use this new method to identify
regulatory genes under the particular conditions and to compare the results with those of other state-of-the-art PCA-based
methods. Promising results on gene expression data have been verified by extensive experiments.
Index Terms—Bi-clustering, Gene expression data, Laplacian embedding, Principal component analysis
——————————  ——————————
1 INTRODUCTION
1.1 Biological analysis of PCA
ith the development of molecular biology, the gene
chip has become one of the most important
technologies of gene functional annotation in the
post-genomic era [1]. Determining how to excavate
reliable information from the high-throughput and
multivariable gene chip to explain the regulatory network
of gene function is the bottleneck problem of
bioinformatics [2]. Without losing the original data,
principal component analysis (PCA) transforms the data
to a low-dimensional linear or nearly linear subspace
constituted by principal components (PCs) [3]. This
method overcomes the limitations of bioinformatics
methods in gene chip analysis and provides new
inspiration for biological data mining. For example, the
selected information simplifies the complexity of the gene
chip variable and clusters the obtained data. This method
provides the basis for early diagnosis and subtyping of
cancer.
1.2 Checkerboard structures in gene expression
data and relations with PCA
In the absence of class knowledge of genes and samples,
it is necessary to find potential classes by exploiting the
relationship between genes and conditions. Bi-clustering
exploits the potential two-sided data structure, which
helps the two-dimensional clustering make meaningful
study of genes and samples. This method has achieved
better results than using single-dimensional clustering to
cluster conditions or features independently [4-7]. Since
the gene expression data generated by gene chip
technology are expressed as a "high-dimensional small-
sample" matrix, we assume that there are "checkerboard"
structures in these data, which is reasonable and effective
[8]. Bi-clustering can be used to find the checkerboard
structures hidden in a gene expression data matrix, which
has been well studied [8]. Specifically, bi-clustering is
performed in both the row and column directions
simultaneously, which interact with and restrain each
other, to identify the checkerboard structures within the
gene expression data, if they exist. These checkerboard
structures are formed by the network of genes and
conditions (e.g., different samples). In the context of
cancer, these structures are associated with significantly
W
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up-regulated or down-regulated genes in patients with
specific types of tumors [8].
The raw gene expression data matrix is presented
graphically in Fig. 1. In this matrix, the rows represent
genes and the columns are different experimental
conditions (e.g., different samples). Under this
assumption, the matrix in Fig. 1 could be reorganized in a
framework with a checkerboard-like structure. The
various blocks in this structure are the strongly correlated
genes (rows) over a subset of samples (columns). Medical
researchers can develop personalized studies of different
patients (samples) with a variety of regulatory genes.
PCA has been well applied in research and has yielded
satisfactory results in clustering [9]. Although the features
selected by PCA retain the main information of the
original variables, and this information is the main part of
the variation, there are weaknesses to this approach. For
example, using limited data to obtain more useful
information is one of the biggest bottlenecks. When PCA
is applied for dimension reduction, it is essential to
introduce manifold learning to learn the internal
geometric structure. It has been proven that the
incorporation of manifold learning into PCA facilitates
the clustering effect [10]. Manifold learning finds the low-
dimensional structure in high-dimensional data, which
reveals the nonlinear geometric structure within the data
[11]. The cross-application of manifold learning and other
techniques has yielded satisfactory results [10, 12].
Nonlinear manifold learning algorithms include
Laplacian Eigenmaps (LE), Isomap, and Locally Linear
Embedding (LLE) [13-15]. For example, Jiang et al.
proposed graph Laplacian PCA (gLPCA) and its robust
model (RgLPCA), which introduced manifold learning
into PCA [10]. Additional improved models based on
gLPCA have been proposed, and good clustering and
feature selection results have been obtained [16].
The methods mentioned above only focus on one-way
clustering, which is solely based on genes or samples and
ignores the relationship between them. Especially for
high-dimensional, sparse and noisy data, it is difficult to
meet the accuracy requirements in practice. As of now,
there are more concerns about bi-clustering, which has
achieved better results than one-way clustering. Bi-
clustering clusters the rows and columns at the same
time, which assist and restrict each other, and is also
effective on high-dimensional and sparse data. In this
paper, we incorporate manifold learning into the PCA
model both in the principal directions (gene manifold)
and along the PCs (condition manifold) to consider the
internal structure of the data. In this way, the chessboard
structures inside the observation data are constructed.
1.3 Uncovering checkerboard structures through
dual graph-regularization PCA
Motivated by recent progress in the PCA method and bi-
clustering [17, 18], we propose a novel method called
dual graph-regularization principal component analysis
(DGPCA). This method simultaneously considers the
internal geometric structures of the condition manifold
and the gene manifold. The geometric structures of the
sample and gene spaces are encoded by constructing two
nearest-neighbor graphs. To summarize, the main
contributions of this paper are as follows:
1. We propose a novel PCA method named DGPCA.
This method simultaneously considers the internal
geometric structure information contained in both
condition and gene data.
2. We present a closed-form solution for this problem
and design an algorithm to address it, which avoids
the instability of the iterative algorithm.
3. A visual checkerboard structure is found by the
proposed method in combination with bi-clustering
in the observed data. This structure corresponds to
the genes that are significantly up-regulated or
down-regulated in patients with certain types of
tumors.
4. To detect new "marker genes" in the checkerboard
structures, we mine the genes that are strongly
regulated under the particular "conditions". These
regulatory genes are more effective than graph-PCA-
based methods. DGPCA provides a tool that is
helpful for the study of the pathogenesis of cancer.
The rest of this paper is organized as follows. First,
several related works are introduced in Section 2,
including graph Laplacian PCA (gLPCA) and its robust
models. Then, the method of DGPCA is first formulated
in Section 3. The closed-form solution of this problem is
also given in this section. Comprehensive experiments are
carried out to evaluate the DGPCA method in Section 4.
Finally, the paper is concluded in Section 5.
Fig. 1. Heat map of identifying checkerboard structures associated
with feature genes and certain conditions. Left: the raw gene
expression data, where each column corresponds to a sample. Right:
the shuffled matrix containing checkerboard structures of conditions
with feature genes.
Notes: All the original figures in this paper can be obtained in the
separate file.
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2 RELATED WORK
Before we present the details of our method, some terms
and notations are listed in Table 1, which will be
frequently used in the following section. Then, we review
some works that are related to this paper.
PCA finds the k -dimensional linear subspace where
the projected data are as close as possible to the original
data [10]. To provide an embedding for the data lying on
a non-linear manifold, graph Laplacian PCA (gLPCA) is
proposed [10]. The main task is to study the data matrix
X that incorporates the cluster information into the
graph data W . This aim can be achieved by solving the
following problem:
2
,
min Tr( ) . . ,T T T
F
γ s t  
U V
X UV V LV V V I (1)
where γ is the parameter that balances the contributions
of the two terms;  L D W is the graph Laplacian matrix,
where ii j ij D W is a diagonal matrix whose elementsare column or row sums of W ; and W is the weight
matrix containing the edge weights of the graph with n
nodes. The definition of ijW can be expressed as follows:
1 ( ) ( ),
0 ,
i k j j k i
ij
if or
otherwise
  
x N x x N x
W (2)
where ( )k iN x is the set of the k -nearest neighbors andedges connecting each data point ix in the graph.The error function of gLPCA minimizes the sum of the
squares of the data points that cause the data to deviate
significantly from the model. To reduce the influence of
outliers and noise, various robust versions of gLPCA
have been proposed. These robust versions are
formulated as follows:
,
min Tr( ) . . ,T T T
z
γ s t  
U V
X UV V LV V V I (3)
where z can be the L2,1-, L1/2- or P-norm. The L2,1-norm is
defined as 2
2,1 1 1 1 2
n d n
ij ij i i     A a a [10]; the
L1/2-norm is defined as 11 221
2 1 1
n d
ijj i  A a [19]; the P-
norm is more flexible and can be tuned from 0 to 1 by a
proximal operator:  1( , ) : max 0, ,ppshrink a α  t t t
where t is a vector and α is the tuning parameter [20].
Good results can be obtained by these methods in feature
selection and clustering. The robust versions utilize the
L2,1-, L1/2- and P-norm in their error functions.
3 METHODOLOGY
3.1 Construct sample and gene graph
Recent research has shown that both the observed
samples and genes lie on nonlinear low-dimensional
manifolds, namely, the sample manifold and gene
manifold, respectively [18]. Thus, we introduce two
graphs to model the internal geometric structures of both
the sample manifold and gene manifold. More
specifically, we construct two graphs with different
dimensions, namely the sample graph and gene graph, to
explore the internal geometric structures of the rows and
columns in gene expression data. The k -nearest-neighbor
sample graph whose vertices correspond to  :,1 :,,..., nx x is
first constructed. Following previous research, we use the
0-1 weighting scheme to construct the k -nearest-neighbor
data graph [10]. The sample weight matrix can be defined
as follows:
  :, :,1, ( ), , 1,..., ,
0, ,
j i
ij
if N
i j n
otherwise
 V
x x
W (4)
where :,( )iN x is the k -nearest neighbor of
:,ix and  V V VL D W is the Laplacian matrix of the
sample, where    jii ij V VD W is a diagonal degree
matrix. Similarly, we also use the 0-1 weighting scheme to
construct the k -nearest-neighbor gene graph.
 1,: ,:,...,T Tdx x is the collection of vertices of the sample
graph. The gene weight matrix is defined as follows:
  ,: ,:1, ( ), , 1,...,
0, ,
T T
j i
ij
if N
i j d
otherwise
  U
x x
W . (5)
The gene graph Laplacian matrix is defined as
 U U UL D W .
3.2 Objective function of dual graph-regularization
PCA
Based on the graph regularizations of the sample
manifold and gene manifold, we propose a new dual
graph-regularization PCA method, with an objective
function that is formulated as follows:
2
,
min Tr( ) Tr( )
. . ,
T T T
F
T
α β
s t
  

U V
U V
X UV U L U V L V
V V I
(6)
where α and β are parameters that balance the
contributions from the reconstruction error of DGPCA in
the first term and the graph regularizations in the latter
two terms. When 0α  , DGPCA degrades to the gLPCA
TABLE 1.
SOME NOTATIONS USED IN THIS PAPER
Notation Description
X data matrix of size d n
n number of samples
d number of genes
k number of clusters
ix i th row of X
:,ix i th column of X
V the PCs of size n k
U the principal directionsof size d k
T r( )A the trace norm of the matrix A
F
A the Frobenius norm of the matrix A
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method, and when 0α β  , DGPCA degrades to the
standard PCA method.
3.3 Closed-form solution of DGPCA
We present a closed-form solution to the problem. The
instability of the iterative solution can be avoided by our
method. The objective function can be rewritten as
follows:
   
   
Tr
Tr Tr
. . .
TT T
GDPCA
T T
T
α β
s t
  
 

U V
X UV X UV
U L U V L V
V V I
l
(7)
First, by computing the optimal U while fixing V , we
can obtain the following results:
   2 0.T Tα       U UX UV V L U L UUl (8)
Thus, the optimal solution of U is given by
1 .U A XV (9)
Here,  1 2 2 Tα α  U UΑ L L . Then, we set 1U A XV
and solve for the optimal V . The objective function
becomes
 21min Tr . . .T T T
F
β s t  VV X A XVV V L V V V I (10)
By some algebra, we have
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As a result, Eq. (10) is equivalent to the following: ( ) minTr . . ,T Ts t 
V
V V BV V V Il (12)
where    1 1 12 T TT T β      VB X A X X A A X L .
Therefore, the optimization problem can be solved by
the eigenvectors corresponding to the k smallest
eigenvalues of the matrix B .
4 EXPERIMENTS
The primary goal of the experiments is to evaluate the
proposed DGPCA method in comparison with gLPCA
because DGPCA incorporates the gene manifold based
on gLPCA. For completeness, we also compare our
results to existing research results and the results of
some other graph-Laplacian-PCA-based methods, such
as RgLPCA [10], L1/2gLPCA [19] and PgLPCA [20].
These methods focus on one-way clustering and only
learn the sample geometry with the PCA method. First,
we present a visual heat-map to display the results of bi-
clustering to find "checkerboard" structures, if they exist.
Then, experiments on selecting regulatory genes are
presented to evaluate the performance of DGPCA
compared with other methods and the existing research
results. Biological analysis of these genes provides the
basis for further research on new cancer markers. The
experimental datasets and the parameter settings for each
method are described in the following subsections.
4.1 Datasets
The datasets used in these experiments are described as
follows:
Leukemia data: The leukemia data consist of a matrix that
includes 38 samples and 5000 genes. This dataset is
publicly available at
https://sites.google.com/site/feipingnie/file. It
contains 11 types of acute myelogenous leukemia
(AML) and 27 types of acute lymphoblastic leukemia
(ALL), and ALL is divided into T- and B-cell
subtypes [21].
Colon cancer data: The colon cancer data consists of a
matrix that includes 2000 genes and 62 tissues. These
tissues are divided into 22 normal and 40 colon
tumor samples [22]. This dataset and its detailed
description are publicly available at
http://genomics-
pubs.princeton.edu/oncology/affydata/index.html
Fig. 2. Heat map of DGPCA bi-clustering result on leukemia (a) and
colon cancer data (b). Left: the checkerboard structure of the leukemia
data, where each column corresponds to a sample. Center: the
principal directions (gene manifold). Right: the projected samples in the
new subspace (condition manifold).
Notes: All the original figures in this paper can be obtained in the
separate file.
AUTHOR ET AL.: TITLE 5
4.2 Experimental setting
For each method, all the parameters are tuned to search
for the optimal value. Since the parameter γ on gLPCA,
RgLPCA, and L1/2gLPCA, and the parameter P on
PgLPCA can be tuned in the range of 0~1, we search for
their optimal values in [0 : 0.1:1] . Within the given range,
the greater the value of γ , the greater the role of the
graph Laplacian in the objective function. According to
previous research, we set 0.5γ  to obtain fair results [10,
19, 20]. In practice, we set the parameter 1.2ρ  in
RgLPCA and L1/2gLPCA. A wider range has also been
investigated, but 1.1 ~ 1.5ρ  yields good results.
Since the parameters α and β of the proposed method
have no special limits, we search for their optimal values
in  4 2 0 2 450 ,50 ,50 ,50 ,50  . We set 0.5β γ  to obtain
the condition manifold because both the parameters β
and γ control the contribution of the graph Laplacian in
the samples. In practice, we find that when 0.05α  ,
satisfactory results can be obtained. Based on the number
of categories of the experimental data, we set the numbers
of reduced dimensions 1 3k  and 2 2k  for leukemiadata and colon cancer data, respectively.
4.3 Bi-clustering results to find “checkerboard”
structure
Our proposed method provides a geometric structure of
not only the condition manifold but also the gene
manifold. To assess our method, it is useful to observe
how well it performs on several gene expression datasets,
with respect to achieving the goal of finding
checkerboard structures. Since the previous PCA-based
methods ignore the joint geometric structures of
conditions and genes, they are not designed to reveal the
checkerboard structures of gene expression data.
Therefore, only the proposed method DGPCA is
evaluated through bi-clustering and the visual heatmap.
We use bi-clustering as a tool for data visualization and
reasonable interpretation of our method. Our method
employs manifold learning schemes that highlight the
internal geometric structures of both genes and
conditions, thereby directly revealing the degree of bi-
clustering.
We apply the proposed method to two publicly
available datasets: leukemia data and colon cancer data.
The visual heatmap is used to display the results of bi-
clustering to find checkerboard structures, if they do exist.
The heat maps of (a) and (b) in Fig. 2 display the bi-
clustering results of DGPCA on the leukemia and colon
cancer data, respectively. In this figure, on the left is the
checkerboard structure of the leukemia data, where each
column corresponds to a sample; in the center are the
principal directions (gene manifold); and on the right are
the projected samples in the new subspace (condition
manifold). The two coordinates represent the sample
number and gene expression level. From Fig. 2, we can
observe that the two raw datasets are rearranged in a
checkerboard structure. In heat map (a), the arrangement
of the 38 samples is generally based on the three types of
labels: AML, T- and B-cells. A similar conclusion can be
drawn from the colon data in heat map (b). The 62 tissues
are generally arranged according to two types of labels
because these tissues are divided into normal and colon
tumor samples. The cross-section of the different colors
shows the interaction between the samples and the genes.
Specifically, blocks of different colors represent the
clustering results of different data classes under the
interaction of the gene and condition manifolds. These
consistently formatted graphs show the checkerboard
structure of each data class on the condition manifold
TABLE 3.
THE DETAILED INFORMATION OF THE PECULIAR GENES ON LEUKEMIA DATA SELECTED BY OUR METHOD, INCLUDING GENE FUNCTION,
ASSOCIATED DISEASE AND RELEVANCE SCORE FOR LEUKEMIA. THIS TABLE LISTS ONLY GENES WITH RELEVANCE SCORES GREATER
THAN 10.
Gene Gene function
Relevance
score
FLT3 This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. 79.21
MYC This functions as a transcription factor that regulates transcription of specific target genes. 42.66
MPO
This is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil
azurophilic granules.
19.06
CCNA1
The protein encoded by this gene belongs to the highly conserved cyclin family, in which members are characterized by a
dramatic periodicity in protein abundance throughout the cell cycle.
14.29
MS4A1 This gene encodes a member of the membrane-spanning 4A gene family. 10.65
CALR This gene acts as an important modulator of the regulation of gene transcription by nuclear hormone receptors. 10.1
TABLE 2.
RESULTS ON TOTAL RELEVANCE SCORES (TRS) OF GLPCA,
RGLPCA, L1/2GLPCA AND DGPCA. THE BEST RESULTS
ARE HIGHLIGHTED IN BOLD.
Data set
leukemia data colon cancer data
TRS ACC ARS TRS ACC ARS
PCA 306.19 53.00 5.78 134.11 22.00 6.10
gLPCA 324.67 55.00 5.90 126.87 22.00 5.77
RgLPCA 306.19 53.00 5.78 134.11 22.00 6.10
L1/2gLPC
A
306.19 53.00 5.78 134.11 22.00 6.10
PgLPCA 384.42 58.00 5.77 147.51 26.00 5.67
DGPCA 395.98 52.00 7.62 243.98 27.00 9.04
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together with the gene manifold.
4.4 Finding regulatory genes under the particular
"conditions"
Since bi-clustering is used as a tool for data visualization
and interpretation, it is natural to detect the quality of bi-
clusters in terms of biological significance or accuracy.
Here, we perform a study to assess the quality of our
method, in which we apply DGPCA to the experimental
data used in this paper. The top-100 regulatory genes are
selected from both the leukemia and colon cancer data for
analysis. First, we rank the scores of all genes in
descending order. Then, the regulatory genes can be
extracted by the corresponding indices. In other words,
the extracted top genes with high scores can be deemed
regulatory genes. DAVID 6.7 is used as a tool to find the
official names of the selected regulatory genes from the
leukemia data; it is publicly available at https://david-
d.ncifcrf.gov/. For the colon cancer data, we search for
the abbreviation of each gene using ToppGene Suite,
which is publicly available at
https://toppgene.cchmc.org/enrichment.jsp. We
download the pathogenic gene pools for leukemia and
colon cancer from GeneCards. This searchable, integrative
database is publicly available at
http://www.genecards.org/. Assume the selected genes
match the pathogenic gene pool over the two
experimental datasets.
4.4.1 Analysis of matching results
The matching results on the leukemia and colon cancer
data of gLPCA, RgLPCA, L1/2gLPCA, PgLPCA and
DGPCA are listed in a separate file. In this file,
regulatory genes are selected by all compared methods,
where the marked genes denote peculiar pathogenic
genes selected by our method but not by other methods.
The relative scores of each regulatory gene associated
with the disease are also listed in this file. To determine
the efficiency of the identified regulatory genes, we
summarize the total relevance scores (TRS), accuracies
(ACC) and average relevance scores (ARS) in Table 2.
The best results are highlighted in bold. ACC is the
accuracy of the regulatory genes from the selected top-
100 genes; it is defined as follows:
  1 ,ACC 100%,ni i iδ p map q
n
  (13)
where iq is a regulatory gene that was selected by ourmethod, and ip is a pathogenic gene of thedisease.   ,i iδ p map q is given by
1, ,
( , )
0, ,
x y
δ x y
otherwise
 
(14)
where  imap q is the mapping function. A higher ACCvalues indicates improved performance. From these
tables, we make the following observations:
1. The lowest TRS are obtained by PCA, on both the
leukemia and colon cancer data. This is reasonable,
since classical PCA is not robust enough.
2. By considering the internal geometric structures,
gLPCA achieves some improvement over classical
PCA.
3. RgLPCA, L1/2gLPCA and PgLPCA also aim at
improving the robustness of the algorithm. PgLPCA
outperforms the others because this method provides
the utmost flexibility, since the value of P can be
tuned from 0 to 1.
4. The ACC result of DGPCA on the colon cancer data is
the highest and that on the leukemia data is the
lowest. The large amount of noise in the leukemia
data might be the main cause, which leads to the
ACC result of DGPCA being less than those of robust
methods such as RgLPCA, L1/2gLPCA and PgLPCA.
These methods are designed to improve the
robustness and reduce the effects of noise and
outliers. However, the TRS and ARS values obtained
by DGPCA are the highest on both datasets because
TABLE 4.
THE DETAILED INFORMATION OF THE PECULIAR GENES ON COLON CANCER DATA SELECTED BY OUR METHOD, INCLUDING GENE
FUNCTION AND RELEVANCE SCORE WITH COLON CANCER. THIS TABLE LISTS ONLY GENES WITH RELEVANCE SCORES GREATER THAN
10.
Gene Gene function
Relevance
score
GSTM1 This gene encodes a glutathione S-transferase that belongs to the mu class. 49.89
SRC
The protein encoded by this gene is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC
kinase.
47.03
Fig. 3. Overlap among the differentially expressed genes identified by
the compared methods.
Notes: All the original figures in this paper can be obtained in the
separate file.
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DGPCA picked out some important genes that were
ignored by the other methods.
4.4.2 Visualization of overlapping results
Here, we utilize a Venn diagram to visualize the overlap
among the regulatory genes selected by the compared
methods. It was obtained using OmicsBean, which is a
multi-omics data analysis tool, which is available at
http://www.omicsbean.com:88/. The Venn diagram in
Fig. 3 shows the following overlapping results: (a) is the
overlapping result on the leukemia data and (b) is the
overlapping result on the colon cancer data. The different
permutations and combinations of all methods are
displayed in the left coordinate of the Venn diagram.
When there is only one method on the left coordinate, the
corresponding number on the right represents a
regulatory gene that is obtained only by this method.
When there are several methods on the left coordinate,
the corresponding number on the right indicates are
regulatory gene that is obtained by these methods.
As shown in Fig. 3, the proposed method selects the
largest number of regulatory genes that are not selected
by other methods. The numbers of such unique
regulatory genes from the two datasets that were
excavated by the proposed method are 18 and 11.
According to the relevance scores in the additional file,
these genes are highly related to disease and cannot be
neglected in the study of leukemia and colon cancer. In
contrast, few unique regulatory genes are excavated by
PgLPCA and gLPCA. Since the relevance scores of these
genes with respect to disease are not high, no further
research on them will be conducted in this paper.
4.4.3 Comparison with published results
To evaluate the promising results of DGPCA, we
compared all related genes, such as biomarker or
characteristic genes, that were obtained by other methods
in the literature, to the regulatory genes found in this
paper. We found that 20 of the 30 genes identified by the
P-norm Robust Feature Extraction (PRFE) method are
related to leukemia and the ARS is 6.56 [23]. Liu et al.
identified the feature genes from leukemia data by
combining RPCA and LDA [24]. Eleven genes were
identified as characteristic genes associated with
leukemia, and the highest relevance score was 19.06. The
average and highest scores of the characteristic genes
selected by RGNMF from the leukemia data were 7.31
and 25.99, respectively[25]. Among all the biomarkers
selected by Wu et al., 29 out of 52 genes selected by our
method can be found in this article [26]. However, the 23
genes they ignored include several important pathogenic
genes, which provide evidence that our method
outperforms the method in the previous study. In
particular, some important genes with high relevance
scores were not excavated in this paper. Some researchers
have made outstanding contributions to the discovery of
colon-cancer-associated genes, but most of the regulatory
genes found in this paper have been neglected [27, 28].
These genes are considered to be new oncogenes and
have research value for leukemia and colon cancer.
Further studies of these genes are conducted in the next
subsection.
4.5 Function analysis of unique regulatory genes
Some genes acquired by DGPCA that have been ignored
by the existing methods are important contributions to
the study of related cancers. Thus, further analysis of
these genes is necessary [26]. We list detailed information
on the unique regulatory genes with relevance scores
greater than 10 in Table 3 and Table 4. These genes will
facilitate the study of leukemia and colon cancer in
clinical practice. The functions and relevance scores of
these genes have been summarized. Some of the results
from these tables and from other research are
summarized as follows:
1. Far more unique regulatory genes are identified by
DGPCA from the leukemia data than from the colon
cancer data. This large disparity is due to the distinct
attributes of different datasets. For example, the
labels of the leukemia data are divided into three
types, whereas those of the colon cancer data are
divided into two types.
2. In Table 3, FLT3 has the highest relevance score with
respect to leukemia in its pathogenic gene pool, and
other methods do not identify this gene. Various
published articles have studied the relationship
between FLT3 and leukemia, which indicates that it is
an important gene in leukemia research [29, 30]. FLT3
is a gene that cannot be ignored in the study of
leukemia, and it highlights the accuracy of our
method. The relevance score of MYC with respect to
leukemia is 42.66. GeneCards indicates that acute
lymphocytic leukemia, acute lymphoblastic 3 and
Burkitt lymphoma are the diseases associated with
this gene. Neither of these genes can be ignored in the
study of leukemia, and they are not found by other
methods. Other genes in Table 3 also have certain
degrees of correlation with leukemia [31, 32]. These
important genes are missing from the 210 leukemia-
related biomarkers identified by Wu et al. [26]. It is
obvious that our results better enhance the clinical
studies of leukemia, compared to those of other
methods. The high relevance scores reflect the close
relationships of CCNA1 and MS4A1 with leukemia.
These results provide a great research space for us to
study these genes, because there is little biological
research on this topic.
3. In Table 4, the relevance scores of GSTM1 and SRC
with respect to leukemia are 49.89 and 47.03,
respectively. Many investigators have conducted
studies on the regulation of these two genes in colon
cancer [33]. Diseases associated with these genes
include colon cancer and lung cancer. It has been
proven in published articles that there is a certain
relationship between them [34, 35]. The above results
demonstrate that our method achieves a more
accurate performance than earlier methods.
4.6 Gene interaction of biological pathway analysis
In addition to analyzing the selected regulatory genes for
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assessing the quality of bi-clusters, it is natural to relate
those genes together with conditions to biological
pathways. We send these selected regulatory genes to
KEGG (http://www.kegg.jp/) to find the biological
pathways. KEGG is a biological database resource for
realizing high-level functions and applying biological
systems. This database provides new perspectives on
genomes, biological pathways, diseases and drugs [36].
The pathway graph of two datasets can be found in
separate file, where the genes in pink are human
disease genes, genes in blue are drug target genes and
green are human genes.
The biological pathways of the hematopoietic cell
lineage record the change process of hematopoietic stem
cells (HSC). These cells can undergo self-renewal or
differentiation into a common lymphoid progenitor (CLP)
or a common myeloid progenitor (CMP). A CLP gives
rise to the lymphoid lineage of white blood cells or the
natural killer (NK) cells of leukocytes on the T and B
lymphocytes. This process increases the production of
platelets and clotting. Therefore, cellular stages are
determined by the specific expression states of these
genes. The interaction of genes selected by our method
precisely describes the work of the hematopoietic system
and is also the major cause of leukemia. The pathways of
ribosome process and translate genetic information.
Kimura et al. conducted studies on the ribosome and
colon cancer cell lines to demonstrate the role of the
ribosome in some biological processes [37]. The above
two biological pathways reflect the interaction of genes in
the corresponding datasets.
5 CONCLUSION
Following the idea of bi-clustering and the relevance of
rows and columns based on gene expression data, this
paper presented a novel method called DGPCA. This
method incorporated the information obtained by the
gene manifold to improve the clustering of conditions in
the model. In particular, the gene and condition
manifolds could be simultaneously obtained by gene
clusters and tumor clusters. The visual heatmap
displayed the results of bi-clustering to find
"checkerboard" structures. In situations where the
checkerboard structure is found, the regulatory genes are
selected compared with those obtained by other PCA-
based methods and those in published articles to evaluate
the quality of the bi-clusters. The identified regulatory
genes have been analyzed in terms of function and co-
expression (pathways). DGPCA provides a tool that is
helpful for the study of the pathogenesis of cancer.
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